SCHEMBL20749124

SCHEMBL20749124

Cc1nc(Cl)sc1CCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HRH2 P25021 10/20 0.36
HRH1 P35367 4/20 0.36
HRH4 Q9H3N8 4/20 0.36
CYP1A2 P05177 1/20 0.36
TKT P29401 1/20 0.34
PIK3CG P48736 1/20 0.33
HRH3 Q9Y5N1 3/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
ADRB2 P07550 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
ADRB1 P08588 1/20 0.31
HTR1A P08908 1/20 0.31
CHRM5 P08912 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD2 P14416 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20749293 0.80 SIRT2 (0.33) TKTSIRT2
SCHEMBL18256087 0.80 ALDH1A1 (0.43) ALDH1A1HRH2HRH1HRH4CYP1A2
SCHEMBL8931356 0.78 ALDH1A1 (0.44) ALDH1A1HPGDTSHRHRH2HRH1
SCHEMBL10282389 0.78 HRH2 (0.39) ALDH1A1HPGDTSHRHRH2HRH1
SCHEMBL7910237 0.73 ALDH1A1 (0.41) ALDH1A1HRH2HRH1HRH4CYP1A2
SCHEMBL8931384 0.69 ALDH1A1 (0.40) ALDH1A1HPGDTSHR
SCHEMBL11150044 0.69 ALDH1A1 (0.53) ALDH1A1HPGDTSHRCYP1A2
Acetic Acid SCHEMBL941257 0.68 ALDH1A1 (0.52) ALDH1A1HPGDTSHR
SCHEMBL261442 0.67 SRC (0.47) HRH2HRH1HRH4CYP1A2TKT
SCHEMBL263398 0.67 ALDH1A1 (0.45) ALDH1A1HRH2HRH1HRH4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3443959-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN Bio-Pharm Solutions Co., Ltd. (KR) 2019-02-20 EP disclosed